Racial differences in chronic lymphocytic leukemia

Digging deeper


  • Christopher R. Flowers MD, MS,

    1. Director, Lymphoma Program; Medical Director, Oncology Data Center; Associate Professor, Bone Marrow and Stem Cell Transplantation, Winship Cancer Institute, Emory University, Atlanta, Georgia
    Search for more papers by this author
  • Barbara Pro MD

    Corresponding author
    1. Professor of Medical Oncology, Chief of Lymphoma Section, Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania
    • Corresponding author: Christopher Flowers, Emory University, Winship Cancer Institute, 1365 Clifton Road NE, Building B, Suite 4302, Atlanta, GA 30322; Fax: (404) 778-5520; crflowe@emory.edu

    Search for more papers by this author


African American patients with untreated chronic lymphocytic leukemia receiving care at The University of Texas MD Anderson Cancer Center and Duke University Medical Center more commonly presented with poor-risk biological features and had worse survival. These results provide additional clinical details to understand the nature of racial disparities in patients with chronic lymphocytic leukemia.